Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Theres no prescription, lab work, or medical oversight
While current technology for creating medical patches does involve microneedles that could theoretically penetrate the skin barrier, no commercially available GLP-1 patch has demonstrated this capability in human trials
Without adequate muscle preservation strategies, many individuals find their weight loss plateaus earlier than expected and weight regain becomes more likely after stopping treatment
Human preclinical studies show that IGF-1 increases myotube nuclei and muscle protein content, leading to enhanced muscle growth and recovery
Retatrutide, a triple agonist targeting all three receptors, is being investigated to address this question, with early data suggesting weight loss of up to 24% in Phase 2
